Cáncer de próstata
Riesgo Cardiovascular
Menopausia y Osteoporosis
Beneficios para la salud
Dermatología
Enfermedades hepáticas
Cáncer de mama
Infertilidad
Endometriosis
Ovario poliquístico
Artritis reumatoide
Abstracts

Cáncer de próstata

Estudios en español

Estudios en inglés

Riesgo Cardiovascular 

Estudios en español

Estudios en inglés

Menopausia y Osteoporosis

Estudios en español

Beneficios para la salud

Estudios en español

Estudios en inglés

Dermatología

Estudios en ingles

Enfermedades hepáticas

Estudios en inglés

Cáncer de mama

Estudios en inglés

Infertilidad

Estudios en inglés

Endometriosis

Estudios en inglés

Ovario poliquístico

Estudios en inglés

Artritis reumatoide

Estudios en inglés

Estudios en español

Abstracts de Licopeno, cáncer, próstata, infertilidad, artritis reumatoide y ovario poliquístico.

Estudios en inglés

Circulating Carotenoids and Subsequent Risk of Rheumatoid Arthritis

Yang Hu , Karen H. Costenbader , Elizabeth W. Karlson and Bing Lu , Brigham and Women’s Hospital, Boston, MA, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA

Lycopene is a more potent inhibitor of human cancer cell proliferation than either α‐carotene or β‐carotene

Levy, Joseph ,  Bosin, Emili , Feldman, Bianca , Giat, Yudit , Miinster, Anat , Danilenko, Michael , Sharoni, Yoav.


Influence of lycopene on cell viability, cell cycle, and apoptosis of human prostate cancer and benign hyperplastic cells.

Soares Nda C1, Teodoro AJ, Oliveira FL, Santos CA, Takiya CM, Junior OS, Bianco M, Junior AP, Nasciutti LE, Ferreira LB, Gimba ER, Borojevic R.


Lycopene modulates growth and survival associated genes in prostate cancer.

Effects of lycopene on protein expression in human primary prostatic epithelial cells.

Diet adherence dynamics and physiological responses to a tomato product whole-food intervention in African-American men.



Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening Era.

Lycopene: redress for prostate cancer.

Lycopene and the LXRa agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPAR?-LXRa-ABCA1 pathway.

Yang CM1, Lu YL, Chen HY, Hu ML.


Epidemiological fundamentals of clinically localized prostate cancer.

[Article in Spanish]

Growth inhibitory efficacy of lycopene and ß-carotene against androgen-independent prostate tumor cells xenografted in nude mice.

Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.

Lycopene modulation of molecular targets affected by smoking exposure.

Palozza P¹, Simone R, Catalano A, Russo M, Bohm V.


Role of lycopene in the control of ROS-mediated cell growth: implications in cancer prevention.

Palozza P¹, Parrone N, Simone R, Catalano A.


Lycopene as a guardian of redox signalling.

Palozza P¹, Catalano A, Simone R, Cittadini A.


Antioxidant and anti-proliferative properties of lycopene.

Kelkel M¹, Schumacher M, Dicato M, Diederich M.


Lycopene: a review of its potential as an anticancer agent.

Bhuvaneswari V¹, Nagini S.


Role of antioxidant lycopene in cancer and heart disease.

Rao AV¹, Agarwal S


Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets.

Liu C¹, Lian F, Smith DE, Russell RM, Wang XD.


Lycopene and chemotherapy toxicity.

Sahin K¹, Sahin N, Kucuk O.


Tomato lycopene and inflammatory cascade: basic interactions and clinical implications.

Palozza P¹, Parrone N, Catalano A, Simone R.


Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells.

Jang SH¹, Lim JW, Morio T, Kim H.


Lycopene effects contributing to prostate health.

Wertz K¹.


Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages.

Palozza P¹, Simone R, Catalano A, Boninsegna A, Böhm V, Fröhlich K, Mele MC, Monego G, Ranelletti FO.


Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.

Karas M¹, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y.


Lycopene protects against trimethyltin-induced neurotoxicity in primary cultured rat hippocampal neurons by inhibiting the mitochondrial apoptotic pathway.

Qu M¹, Zhou Z, Chen C, Li M, Pei L, Chu F, Yang J, Wang Y, Li L, Liu C, Zhang L, Zhang G, Yu Z, Wang D.


Free radicals and antioxidants in normal physiological functions and human disease.

Valko M¹, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J.


Lycopene, a natural antioxidant.

[Article in Hungarian]

Bánhegyi G¹.


Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines.

Ivanov NI¹, Cowell SP, Brown P, Rennie PS, Guns ES, Cox ME.


The carotenoid lycopene differentially regulates phase I and II enzymes in dimethylbenz[a]anthracene-induced MCF-7 cells.

Wang H¹, Leung LK.


Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells.

Tang FY¹, Cho HJ, Pai MH, Chen YH.


Inhibitory effect of lycopene on PDGF-BB-induced signalling and migration in human dermal fibroblasts: a possible target for cancer.

Wu WB¹, Chiang HS, Fang JY, Hung CF.


Lycopene inhibits cell migration and invasion and upregulates Nm23-H1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells.

Huang CS¹, Shih MK, Chuang CH, Hu ML.


Lycopene and apo-12′-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells.

Ford NA¹, Elsen AC, Zuniga K, Lindshield BL, Erdman JW Jr.


Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells.

Hantz HL¹, Young LF, Martin KR.


The role of lycopene and its derivatives in the regulation of transcription systems: implications for cancer prevention.

Sharoni Y¹, Linnewiel-Hermoni K, Zango G, Khanin M, Salman H, Veprik A, Danilenko M, Levy J.


Influence of lycopene on cell viability, cell cycle, and apoptosis of human prostate cancer and benign hyperplastic cells.

Soares Nda C¹, Teodoro AJ, Oliveira FL, Santos CA, Takiya CM, Junior OS, Bianco M, Junior AP, Nasciutti LE, Ferreira LB, Gimba ER, Borojevic R.


Lycopene modulates growth and survival associated genes in prostate cancer.

Rafi MM¹, Kanakasabai S, Reyes MD, Bright JJ.


Effects of lycopene on protein expression in human primary prostatic epithelial cells.

Qiu X¹, Yuan Y, Vaishnav A, Tessel MA, Nonn L, van Breemen RB.


Lycopene: redress for prostate cancer.

Pisipati SV¹, Pathapati H¹, Bhukya G¹, Nuthakki S¹, Chandu B¹, Nama S¹, Adeps R¹.
Free PMC Article


Dietary tomato and lycopene impact androgen signaling- and carcinogenesis-related gene expression during early TRAMP prostate carcinogenesis.

Wan L1Tan HL1Thomas-Ahner JM2Pearl DK3Erdman JW Jr4Moran NE2Clinton SK5.


Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.

Graff RE1Pettersson A2Lis RT3Ahearn TU4Markt SC4Wilson KM5Rider JR5Fiorentino M6Finn S7Kenfield SA8Loda M3Giovannucci EL9Rosner B10Mucci LA5.


Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer.

Nordström T1,2,3Van Blarigan EL1,2Ngo V1Roy R4Weinberg V5Song X6Simko J1,7Carroll PR1Chan JM1,2Paris PL1.


Mechanism of the Anticancer Effect of Lycopene (Tetraterpenoids).

Ono M1Takeshima M1Nakano S2.


 Impact of oxidative stress on female fertility

Ruder EH , Hartman TJ , Goldman MB.


Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome

Mansour A , Hosseini S , Larijani B , Mohajeri-Tehrani MR.


Female dietary antioxidant intake and time to pregnancy among couples treated for unexplained infertility

Ruder EH , Ph.D., M.P.H , Hartman TJ , Reindollar RH , Goldman MB , Sc.D.


 

Desarrollo web Quadralia | Diseño: juáncho | DEBUXA & DESEÑA